Thursday 2 November 2023
07:45
Chris Wigley
Genomics and Healthcare
Genomics England, in partnership with the NHS and the research community, is at the forefront of bringing genomics insights to inform health and care at population scale. Chris, will discuss and explain:
- the foundational science that underpins this work
- the ‘state of the nation’ for deploying genomic science in healthcare, in rare diseases, cancer and beyond
- critical considerations around sustaining and reinforcing ethics and trust
- what we can expect to see in the coming years as the field continues to advance and move into the mainstream

Chris is CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care. Previously he was COO at QuantumBlack and a Partner at McKinsey. He is a trustee of the New Entrepreneurs Foundation, on the Advisory Board of deep-tech VC Entrepreneur First and previously worked for the UK Foreign Office, in the counter Terrorism Policy Department.
CEO of Genomics England
Chris is CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care. Previously he was COO at QuantumBlack and a Partner at McKinsey. He is a trustee of the New Entrepreneurs Foundation, on the Advisory Board of deep-tech VC Entrepreneur First and previously worked for the UK Foreign Office, in the counter Terrorism Policy Department.